Security key
05070R104
- Security type / class
- Equity / COM
- Total 13F shares
- 34,677,880
- Total 13F value
- $1,042,053,309
- Share change
- +8,804,128
- Put/Call ratio
- 113%
- SEC-reported price per share
- $30.05
- Number of holders
- 112
- Value change
- +$263,768,588
- Number of buys
- 84
- Number of sells
- 23
Open additional details 1 more signal available
Report period
Q1 2018
Institutions
112
Top holders
10
BOLD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2018
Previous quarter: Q4 2017
Boundless Bio, Inc. SEC filings
Boundless Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05070R104
Recent filing periods:
Ownership snapshot
Top reported holders of BOLD - AUDENTES THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
31 Dec 2017
13F
Highest disclosed value: $137,864,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $137.86M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$137.86M
ORBIMED ADVISORS LLC
$129.05M
PRICE T ROWE ASSOCIATES INC /MD/
$48.29M
BlackRock Finance, Inc.
$42.45M
Versant Venture Management, LLC
$37.64M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
class O/S missing
|
$137,864,000
4,411,633 shares
|
— | 31 Dec 2017 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$129,051,000
4,129,638 shares
|
— | 31 Dec 2017 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
class O/S missing
|
$48,293,000
1,545,377 shares
|
— | 31 Dec 2017 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$42,452,000
1,358,498 shares
|
— | 31 Dec 2017 |
| Versant Venture Management, LLC |
13F
Company
|
—
class O/S missing
|
$37,644,219
1,204,615 shares
|
— | 31 Dec 2017 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
—
class O/S missing
|
$37,204,000
1,190,516 shares
|
— | 31 Dec 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
112
Shares
34,677,880
Rows available
112
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
86
Q1 2018 holders
112
Holder diff
26
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 value | Q1 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend